New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Johnson & Johnson

JNJ

Healthcare Drug Manufacturers General

Johnson & Johnson’s revenue for fiscal 2025 (year ended December 2025) was $94.2 billion, up 6.05% from fiscal 2024.

Revenue
+5.86%
EPS
−95.8%
Free cash flow
−21.4%
Total debt
−9.16%

Quarter to September 2026, against a year earlier

271.02 3.92 +1.47%
Market cap
$650.7B
P/E
40.5×
Fwd P/E FY26e
41.8×
Dividend yield
1.98%
F-score
3/9
ROIC
11.1%
Net debt / EBITDA
0.5×
Payout ratio
0.8×

Johnson & Johnson (JNJ) EV/EBITDA

Alert me on EV/EBITDA

As of Nov 19, 2026, Johnson & Johnson (JNJ) trades at a EV/EBITDA of 23.9×. Over the past ten years it has ranged from 9.2× (August 2015) to 25.5× (November 2026); the current reading is higher than 99% of that period. That is above the Drug Manufacturers General industry median of 13.9× and above the Healthcare sector median of 8.5×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 12.3× (9.41%)
FY2024 13.6× (18.31%)
FY2023 16.6× (4.74%)
FY2022 17.4× 4.16%
FY2021 16.7× (4.60%)
FY2020 17.5× 11.65%
FY2019 15.7× 17.82%
FY2018 13.3× (15.14%)
FY2017 15.7× 30.18%
FY2016 12.1× 10.03%

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 23.7× 31.68%
Jun 2026 18.0× 3.32%
Mar 2026 17.4× 41.82%
Dec 2025 12.3× 7.50%
43 more quarters

Against its own ten years

Low 9.2× High 25.5×
Ten-year median 14.7×
Current reading's percentile 99

EV/EBITDA against peers

Company EV/EBITDA
PFE Pfizer Inc. compare 10.2×
AZN AstraZeneca PLC compare 13.9×
NVS Novartis AG compare 14.6×
AMGN Amgen Inc. compare 16.2×
ABBV AbbVie Inc. compare 19.8×
JNJ Johnson & Johnson 23.9×
MRK Merck & Co., Inc. compare 27.1×
LLY Eli Lilly and Company compare 33.9×
GILD Gilead Sciences, Inc. compare 502×
Drug Manufacturers General industry median 13.9×
Healthcare sector median 8.5×
Market median 10.4×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on JNJ